Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus
Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy
Improving lopinavir genotype algorithm through phenotype correlations
The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants
A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients
Didanosine, interferon-alfa and ribavirin
Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infection
Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
The contribution of steady and casual partnerships to the incidence of HIV infection among homosexual men in Amsterdam
The economic impact of HIV/AIDS on the education sector in Zambia
A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa
Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi
Brazilian Network for HIV Drug Resistance Surveillance (HIV-BResNet)
HIV incidence among street youth in Montreal, Canada
Genotype–phenotype discordance
District-randomized phased implementation
Primary resistance mutations to fusion inhibitors and polymorphisms in gp41 sequences of HIV-1 non-B subtypes and recombinants
Antiretroviral resistance associated with supervised treatment interruptions in treated acute HIV infection
Dynamics of viral load rebound in plasma and semen after stopping effective antiretroviral therapy
Lopinavir
Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathy
The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination
Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens
Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy
High prevalence of CRF02_AG and many minor resistance-related mutations at the protease gene among HIV-infected treatment-naive immigrants in Madrid
Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoring
High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors
Progressive outer retinal necrosis in a 73-year-old man
Primary cerebral lymphoma presenting as diffuse leukoencephalopathy
HIV prevalence during pregnancy in Tijuana, Baja California, Mexico
HIV/AIDS prevention programs in developing countries are deficient without an appropriate scientific research infrastructure
Remarks on ‘A stochastic model for the primary HIV infection